CPST1

Cytori Therapeutics: The Stem Cell 'Celution' for Success

www.artecel.com/docs/A...


On Jul 07 12:56 PM Regenerative Review wrote:

> What this author/shareholder glaringly fails to mention is that Cytori
> just lost their license to the global rights to the human adipose
> stem cells when UCLA lost their patent dispute with the University
> of Pittsburg. So, while they may have a machine to process the adipose,
> they have no rights to do so. The company deceptively plays down
> the significance of this ominous event in their press release. In
> my opinion, Cytori is a massive short sale candidate as the stock
> is poised to take a free fall!